Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

N. R. Sluiter; E. M. V. de Cuba; R. Kwakman; W. J. H. J. Meijerink; P. M. Delis-van Diemen; V. M. H. Coupe; J. A. M. Belien; G. A. Meijer; I. H. J. T. de Hingh; E. A. te Velde

doi:10.1007/s10585-016-9779-9

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

N. R. Sluiter, E. M. V. de Cuba, R. Kwakman, W. J. H. J. Meijerink, P. M. Delis-van Diemen, V. M. H. Coupe, J. A. M. Belien, G. A. Meijer, I. H. J. T. de Hingh, E. A. te Velde

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	297-307
Journal	Clinical & experimental metastasis
Volume	33
Issue number	4
DOIs	https://doi.org/10.1007/s10585-016-9779-9
Publication status	Published - Apr 2016

Access to Document

10.1007/s10585-016-9779-9

Cite this

Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupe, V. M. H., Belien, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., & te Velde, E. A. (2016). Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Clinical & experimental metastasis, 33(4), 297-307. https://doi.org/10.1007/s10585-016-9779-9

@article{f12c7e030efb4f44b64554708aed27c0,

title = "Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy",

keywords = "Peritoneal metastases, Colorectal cancer, HIPEC, Versican, VEGF, Angiogenesis, Biomarkers",

author = "Sluiter, {N. R.} and {de Cuba}, {E. M. V.} and R. Kwakman and Meijerink, {W. J. H. J.} and {Delis-van Diemen}, {P. M.} and Coupe, {V. M. H.} and Belien, {J. A. M.} and Meijer, {G. A.} and {de Hingh}, {I. H. J. T.} and {te Velde}, {E. A.}",

year = "2016",

month = apr,

doi = "10.1007/s10585-016-9779-9",

language = "English",

volume = "33",

pages = "297--307",

journal = "Clinical & experimental metastasis",

issn = "0262-0898",

publisher = "Springer Netherlands",

number = "4",

}

Sluiter, NR, de Cuba, EMV, Kwakman, R, Meijerink, WJHJ, Delis-van Diemen, PM , Coupe, VMH , Belien, JAM, Meijer, GA, de Hingh, IHJT & te Velde, EA 2016, 'Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy', Clinical & experimental metastasis, vol. 33, no. 4, pp. 297-307. https://doi.org/10.1007/s10585-016-9779-9

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. / Sluiter, N. R.; de Cuba, E. M. V.; Kwakman, R. et al.

In: Clinical & experimental metastasis, Vol. 33, No. 4, 04.2016, p. 297-307.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

AU - Sluiter, N. R.

AU - de Cuba, E. M. V.

AU - Kwakman, R.

AU - Meijerink, W. J. H. J.

AU - Delis-van Diemen, P. M.

AU - Coupe, V. M. H.

AU - Belien, J. A. M.

AU - Meijer, G. A.

AU - de Hingh, I. H. J. T.

AU - te Velde, E. A.

PY - 2016/4

Y1 - 2016/4

KW - Peritoneal metastases

KW - Colorectal cancer

KW - HIPEC

KW - Versican

KW - VEGF

KW - Angiogenesis

KW - Biomarkers

U2 - 10.1007/s10585-016-9779-9

DO - 10.1007/s10585-016-9779-9

M3 - Article

VL - 33

SP - 297

EP - 307

JO - Clinical & experimental metastasis

JF - Clinical & experimental metastasis

SN - 0262-0898

IS - 4

ER -

Sluiter NR, de Cuba EMV, Kwakman R, Meijerink WJHJ, Delis-van Diemen PM , Coupe VMH et al. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Clinical & experimental metastasis. 2016 Apr;33(4):297-307. doi: 10.1007/s10585-016-9779-9